Scantox has developed a significant footprint in toxicology and preclinical lead optimization over the past few decades.
Scantox services support a broad spectrum of preclinical drug development elements. From lead optimization within in vitro and in vivo efficacy models, formulation development regulatory toxicology studies incl. supportive functions as clinical pathology, bioanalysis, histology all the way to manufacturing and distribution of products for clinical trial phase 1 and 2. This enables clients to progress their development projects under one roof in a trustworthy collaborative matter based on the highest technical and scientific standards.
Read more about Scantox here